Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

NCT05089916 is registered in ClinicalTrials.gov with AIO-Studien-gGmbH as lead sponsor.

NCT NCT05089916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05089916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study
Lead sponsor
AIO-Studien-gGmbH
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 20, 2022
Completion date
March 31, 2027
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr positive non-small cell lung cancer, nsclc, oligoprogression